SUO 2020 GU Malignancies Non-Prostate

Viewing 1-20 of 48 articles

SUO 2020: Patterns of Recurrence After Inguinal Lymph Node Dissection for Penile Squamous Cell Carcinoma

SUO 2020: Adverse Event Profile for Combination Chemoimmunotherapy Compared to Chemotherapy in Solid Organ Malignancies: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

SUO 2020: Perioperative Therapy for Muscle-Invasive Bladder Cancer

SUO 2020: Clinically Node-Positive Bladder Cancer – Pro Surgery

SUO 2020: Real-World Application of Pre-Orchiectomy miR-371A-3P Test in Testicular Germ Cell Tumor Management

SUO 2020: Oncologic Outcomes of Mohs Surgery for Localized Penile Carcinoma: A 10-Year Retrospective Study

SUO 2020: Neoadjuvant Checkpoints: Exploring the Emerging Utility of Immune Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer

SUO 2020: Advanced Kidney Cancer Update – “A Glimpse into the Future"

SUO 2020: Systemic Therapy for Metastatic Urothelial Carcinoma

SUO 2020: Management of “Node Only” M1 Metastatic Bladder Cancer- Against Surgery

SUO 2020: Debate: Neoadjuvant vs. Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma - Adjuvant

SUO 2020: Genomic Characterization of Residual Disease at Radical Cystectomy Following Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer

SUO 2020: Factors Associated with Decision Regret in Patients Undergoing Radical Cystectomy and Urinary Diversion

SUO 2020: Racial and Socioeconomic Disparities In Adjuvant Therapy and Survival In Nonseminomatous Germ Cell Tumor: A Population-Based Study

SUO 2020: Debate: Neoadjuvant vs. Adjuvant Chemotherapy for UTUC - Neoadjuvant

SUO 2020: Emerging Management of Von Hippel-Lindau-associated Renal Cell Carcinoma

SUO 2020: Optimizing Management of High Risk Non-Muscle-Invasive Bladder Cancer – Case Based Discussion

SUO 2020: Molecular Characterization of NMIBC in the Clinical Context

SUO 2020: Next Generation Clinical Trial Design BCG-Unresponsive NMIBC

SUO 2020: Final Results of the OLYMPUS Study - Durability of Response to Chemoablative Treatment of Low-Grade Upper Tract Urothelial Carcinoma with a Mitomycin-Containing Reverse Thermal Hydrogel

1
2
3